ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Addition Therapeutics
The Director, Preclinical Development will lead scientific strategy and execution of integrated preclinical programs for the PRINT™ platform, overseeing in vivo pharmacology, nonclinical safety, and IND-enabling activities. This role involves managing CROs, collaborating across cross‑functional teams, and mentoring scientists to advance therapeutic candidates toward clinical trials.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Addition Therapeutics.
12% below the average for this role
VP, Head of Preclinical Development
Legend Biotech
Vice President, Preclinical & Clinical Development
Scripps Research
Advisor – RNA Preclinical Pharmacology
Eli Lilly and Company
Executive Director / Vice President, Biology & Translational Pharmacology
Profluent
Director of In Vivo Pharmacology
Flagship Pioneering, Inc.
Director or Senior Director, Preclinical Pharmacology/Toxicology
Viking Therapeutics